Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 800 of 2026 entries
View as:

A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00488059 Org: User:
Start: 06/30/07 End: 10/31/08 Due: 10/31/09

A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01224106 Org: User:
Start: 11/30/10 End: 09/10/20 Due: 09/10/21

A Study of the Relative Bioavailability of Single Dose RO4917838 and the Effect of Food in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01665976 Org: User:
Start: 08/31/12 End: 11/30/12 Due: 11/30/13

A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER)

Phase: N/A Priority: Normal
NCT ID: NCT01235507 Org: User:
Start: 02/28/11 End: 12/31/12 Due: 12/31/13

Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01877811 Org: User:
Start: 06/30/13 End: 02/28/19 Due: 02/28/20

A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02103595 Org: User:
Start: 11/01/13 End: 06/30/14 Due: 06/30/15

A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00776698 Org: User:
Start: 04/30/09 End: 02/28/10 Due: 02/28/11

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT05155345 Org: User:
Start: 01/11/22 End: 12/17/24 Due: 12/17/25

A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05646862 Org: User:
Start: 06/07/23 End: 03/30/29 Due: 03/30/30

A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01871415 Org: User:
Start: 05/31/13 End: 08/31/13 Due: 08/31/14

A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum

Phase: N/A Priority: Normal
NCT ID: NCT01131078 Org: User:
Start: 06/30/05 End: 11/30/12 Due: 11/30/13

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01609036 Org: User:
Start: 10/31/12 End: 11/30/12 Due: 11/30/13

An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01072240 Org: User:
Start: 09/30/09 End: 06/30/11 Due: 06/30/12

A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.

Phase: N/A Priority: Normal
NCT ID: NCT00364832 Org: User:
Start: 10/31/01 End: 07/31/05 Due: 07/31/06

A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01519336 Org: User:
Start: 02/29/12 End: 03/31/12 Due: 03/31/13

A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT03135262 Org: User:
Start: 06/15/17 End: 04/30/20 Due: 04/30/21

A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT02479386 Org: User:
Start: 06/24/15 End: 01/31/18 Due: 01/31/19

Quality of Life Study in Participants With IPF Under Pirfenidone Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03115619 Org: User:
Start: 04/18/17 End: 01/10/20 Due: 01/10/21

A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02465606 Org: User:
Start: 07/30/15 End: 05/30/16 Due: 05/30/17

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT02622321 Org: User:
Start: 11/18/15 End: 12/01/20 Due: 12/01/21

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00642577 Org: User:
Start: 07/31/07 End: 12/31/10 Due: 12/31/11

A Study of Gantenerumab in Participants With Mild Alzheimer Disease

Phase: N/A Priority: Normal
NCT ID: NCT02051608 Org: User:
Start: 03/27/14 End: 04/16/21 Due: 04/16/22

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Phase: N/A Priority: Normal
NCT ID: NCT00487747 Org: User:
Start: 08/31/06 End: 10/31/09 Due: 10/31/10

A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).

Phase: N/A Priority: Normal
NCT ID: NCT04422210 Org: User:
Start: 09/22/20 End: 11/06/20 Due: 11/06/21

A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT01277094 Org: User:
Start: 04/30/11 End: 03/31/12 Due: 03/31/13